 | • レポートコード：MRC2303I0116 • 出版社/出版日：Mordor Intelligence / 2023年1月23日 • レポート形態：英文、PDF、120ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社の本調査レポートでは、世界の薬物スクリーニング市場規模が、予測期間中に年平均12.4%で成長すると予測しています。本レポートは、薬物スクリーニングの世界市場について調べ、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、製品＆サービス別（消耗品、機器、迅速検査装サービス）分析、試料種類別（尿サンプル、口腔液サンプル、毛髪サンプル、その他）分析、エンドユーザー別（薬物検査機関、病院、その他）分析、地域別（アメリカ、カナダ、メキシコ、ドイツ、イギリス、フランス、イタリア、スペイン、中国、日本、インド、オーストラリア、韓国、中東、南アフリカ、ブラジル、アルゼンチン）分析、競争状況、市場機会・将来の動向などを以下の構成でまとめています。また、LabCorp、Quest Diagnostics、Abbott Laboratories、Thermo Fisher Scientific, Inc.、Alfa Scientific Designs, Inc.、OraSure Technologies, Inc.、Siemens Healthineers、Roche、Shimadzu、LifeLoc Technologies、Dragerwerk、Premier Biotech, Inc.などの企業情報が含まれています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界の薬物スクリーニング市場規模：製品＆サービス別 - 消耗品の市場規模 - 機器の市場規模 - 迅速検査装サービスの市場規模 ・世界の薬物スクリーニング市場規模：試料種類別 - 尿サンプルの市場規模 - 口腔液サンプルの市場規模 - 毛髪サンプルの市場規模 - その他試料の市場規模 ・世界の薬物スクリーニング市場規模：エンドユーザー別 - 薬物検査機関における市場規模 - 病院における市場規模 - その他エンドユーザーにおける市場規模 ・世界の薬物スクリーニング市場規模：地域別 - 北米の薬物スクリーニング市場規模 アメリカの薬物スクリーニング市場規模 カナダの薬物スクリーニング市場規模 メキシコの薬物スクリーニング市場規模 … - ヨーロッパの薬物スクリーニング市場規模 ドイツの薬物スクリーニング市場規模 イギリスの薬物スクリーニング市場規模 フランスの薬物スクリーニング市場規模 … - アジア太平洋の薬物スクリーニング市場規模 中国の薬物スクリーニング市場規模 日本の薬物スクリーニング市場規模 インドの薬物スクリーニング市場規模 … - 中東/南米の薬物スクリーニング市場規模 南アフリカの薬物スクリーニング市場規模 ブラジルの薬物スクリーニング市場規模 アルゼンチンの薬物スクリーニング市場規模 … - その他地域の薬物スクリーニング市場規模 ・競争状況 ・市場機会・将来の動向 |
The Drug Screening Market is expected to register a CAGR of 12.4% during the forecast period.
The impact of the COVID-19 pandemic on the market is expected to be significant. According to a recent survey conducted by the Current Consulting Group (CCG) in August 2020, about 21% of employers have reported a decline of 61% or more in the number of drug tests undertaken on their employees during the pandemic. This is attributed to several factors, including a decrease in the number of people being tested because of an increase in the number of employees working from home and general concerns about workplace drug testing safety and COVID-19 safeguards. Also, as per the research article published in Population Health Management, 2021, a significant decrease in the testing for prescription and illicit drugs was observed, with a weekly test volume decrease of 70%. Thus, decreased drug screening is expected to impact the market during the pandemic.
The key factor driving the global drug screening market are increased drug and alcohol consumption, strict alcohol and drug testing legislation, government funding for pharmaceutical development, and regulatory approvals. According to the World Drug Report 2021 published by United Nations Office on Drugs and Crime (UNODC), the number of people using drugs increased by 22% between 2010 and 2019. As per the UNODC findings, around 200 million people smoked cannabis in 2019, which accounted for 4% of the global population. Furthermore, according to the same source, the number of cannabis users increased by around 18% between 2010 to 2019. In addition, around 20 million people consumed cocaine in 2019, which accounted for 0.4% of the global population. Thus, the rising consumption of drugs among the population is expected to increase the demand for drug screening, in turn, fueling the overall market growth in the studied period.
However, prohibitions on the consumption of alcohol and drugs in some countries, as well as restrictions prohibiting drug testing at work, particularly in developed economies may hinder the global drug screening market’s growth.
Drug Screening Market Trends
Urine Sample Segment is Expected to Dominate Over the Forecast Period
Urine testing is one of the most common testing methods for drugs. Benefits associated with urine testing such as noninvasiveness and the ability to detect large numbers of drugs in the sample are expected to drive the segment growth over the forecast period. Urine testing can detect drugs used within 1 to 4 days, sometimes even longer.
Urine drug testing is an important part of monitoring patients with long-term opioid therapy, and it has been suggested for patients receiving long-term benzodiazepine or stimulant therapy too. Also, it is one of the crucial tests to check opioid dependency. Thus, the rising prevalence of opioid overdose is expected to drive market growth over the forecast period. For instance, according to the World Health Organization 2021, opioids include compounds that are extracted from the poppy seed as well as synthetic and semi-synthetic compounds with similar properties that can interact with brain opioid receptors. According to the same source, about 275 million people (or 5.5% of the global population aged 15-64 years) used drugs at least once in 2019 globally. Among them, approximately 62 million people used opioids.
Additionally, as per the research article published in the Journal of Applied Laboratory Medicine, 2020, there has been an increased adoption in the targeted panel of urine drug testing, and the value of clinical urine drug testing was observed to have improved by providing laboratory-based results interpretation and consultative services. Thus, owing to the aforementioned factors, the studied segment is expected to witness healthy growth over the forecast period.
North America Leads the Global Drug Screening Market
North America dominates the drug screening industry due to the serious problem related to high levels of alcohol intake. Also, increasing consumption of illegal drugs, the availability of government funding to combat drug abuse, and the existence of strict rules in the country are encouraging drug screening. For instance, in April 2022, Quest Diagnostics performed drug testing and collected 11 million unidentifiable urine, hair, and oral fluid sample results between January and December 2021. According to Quest Diagnostics’ annual drug index data published in March 2022, with 7.5 percent of employees testing were positive for marijuana between January and December 2021. According to the same report, based on over six million urine samples, marijuana had the highest positive rates in the United States workforce increasing by 8.3% in the same period. Hence, the rising consumption of drugs among people is expected to increase the demand for drug screening tests, in turn, benefitting the overall market growth.
Furthermore, various initiatives are being implemented by the United States government to monitor the symptoms and to determine whether a person is under drug abuse. For instance, the Patients and Communities Act of 2018 was a law implemented by the country to counter-acting drug abuse. Thus, the rising drug and alcohol abuse and strict regulations to detect intoxication in the body are expected to help the market growth in the region over the forecast period.
Drug Screening Market Competitor Analysis
The key players operating in the global drug screening market are LabCorp, Quest Diagnostics, Abbott Laboratories, Thermo Fisher Scientific, Inc., Alfa Scientific Designs, Inc., OraSure Technologies, Inc., Siemens Healthineers, Roche, Shimadzu, LifeLock Technologies, Drägerwerk, and Premier Biotech, Inc.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Drug & Alcohol Consumption
4.2.2 Enforcement of Stringent Laws Mandating Drug & Alcohol Testing
4.3 Market Restraints
4.3.1 Ban on Alcohol Consumption in Several Islamic Countries
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size by Value – USD million)
5.1 By Product and Service
5.1.1 Consumables
5.1.2 Instruments
5.1.3 Rapid Testing Devices
5.1.4 Services
5.2 By Sample Type
5.2.1 Urine Samples
5.2.2 Oral Fluid Samples
5.2.3 Hair Samples
5.2.4 Other Samples
5.3 By End User
5.3.1 Drug Testing Laboratories
5.3.2 Hospitals
5.3.3 Others
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 LabCorp
6.1.2 Quest Diagnostics
6.1.3 Abbott Laboratories
6.1.4 Thermo Fisher Scientific, Inc.
6.1.5 Alfa Scientific Designs, Inc.
6.1.6 OraSure Technologies, Inc.
6.1.7 Siemens Healthineers
6.1.8 Roche
6.1.9 Shimadzu
6.1.10 LifeLoc Technologies
6.1.11 Dragerwerk
6.1.12 Premier Biotech, Inc.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS